Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Hundreds of millions of people worldwide await treatments for rare diseases.
Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.
In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.